Rampart Bioscience
Healthcare & Life Sciences
Recent Finacing
Series A
Recent Raise
$85M
Rampart Bioscience is a biotechnology company developing next-generation biologics using their proprietary DNA-based medicines platform, HALO, with a focus on treating hypophosphatasia.
Focus Areas
Biotechnology
Gene Therapy
DNA-based Medicines
Hypophosphatasia Treatment
Non-viral Gene Approaches
Rare Genetic Diseases
Investors
